- Previous Close
252.68 - Open
254.00 - Bid --
- Ask --
- Day's Range
249.20 - 254.13 - 52 Week Range
217.05 - 273.69 - Volume
775,123 - Avg. Volume
1,377,955 - Market Cap (intraday)
70.769B - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
33.90 - EPS (TTM)
7.36 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield 2.60 (1.04%)
- Ex-Dividend Date Mar 18, 2025
- 1y Target Est
284.24
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four reportable segments: Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, refining, pulp and paper, and petrochemical industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. The Global Healthcare & Life Sciences segment offers cleaning and sanitizing products, such as infection prevention, and end-to-end cleaning and contamination control solutions to the healthcare, personal care, and pharmaceutical industries under the Ecolab, Bioquell, Purolite, and Anios brand names. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
www.ecolab.com48,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ECL
View MorePerformance Overview: ECL
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ECL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ECL
View MoreValuation Measures
Market Cap
70.77B
Enterprise Value
77.80B
Trailing P/E
33.85
Forward P/E
33.22
PEG Ratio (5yr expected)
2.24
Price/Sales (ttm)
4.54
Price/Book (mrq)
8.08
Enterprise Value/Revenue
4.94
Enterprise Value/EBITDA
20.22
Financial Highlights
Profitability and Income Statement
Profit Margin
13.42%
Return on Assets (ttm)
7.55%
Return on Equity (ttm)
25.29%
Revenue (ttm)
15.74B
Net Income Avi to Common (ttm)
2.11B
Diluted EPS (ttm)
7.36
Balance Sheet and Cash Flow
Total Cash (mrq)
1.4B
Total Debt/Equity (mrq)
103.91%
Levered Free Cash Flow (ttm)
1.93B